Christof Spitzley

This inventor holds 7 USPTO granted patents and 8 published patent applications, plus 3 CIPO patents and 6 EPO patents. Top assignees: Purdue Pharma L.p., Euro-Celtique S.a.. Active years: 2004-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christof Spitzley. Retrieved from https://idiyas.com/inventor/christof-spitzley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 8)

% Patents Active = 71.4

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 18)

Average Co-Inventor Count = 3.1

ph-index = 4

Forward Citations = 106(Granted Patents)

Location History:

Elbtal-Heuchelheim, DE (2004)
Eibtal, DE (2014)
Elbtal, DE (2014 - 2019)

Company Filing History:

Years Active: 2004-2019

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10420762 - Pharmaceutical preparation containing oxycodone and naloxone (2019-09-24),

2. 9907793 - Pharmaceutical preparation containing oxycodone and naloxone (2018-03-06),

3. 9655855 - Matrix for sustained, invariant and independent release of active compounds (2017-05-23),

4. 9555000 - Pharmaceutical preparation containing oxycodone and naloxone (2017-01-31),

5. 8846091 - Matrix for sustained, invariant and independent release of active compounds (2014-09-30),

6. 8846090 - Matrix for sustained, invariant and independent release of active compounds (2014-09-30),

7. 6806294 - Opioid analgesic (2004-10-19),

Title: Christof Spitzley: Innovator in Pharmaceutical Preparations

Introduction

Christof Spitzley is a notable inventor based in Elbtal, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in pain therapy. With a total of 7 patents to his name, Spitzley has demonstrated a commitment to advancing medical treatments.

Latest Patents

One of his latest inventions is a pharmaceutical preparation containing oxycodone and naloxone. This innovative formulation is designed to be storage stable and allows for the active compounds to be released in a sustained, invariant, and independent manner. This invention aims to improve pain management while addressing potential misuse of opioids.

Career Highlights

Throughout his career, Christof Spitzley has worked with reputable companies such as Purdue Pharma L.P. and Euro-Celtique S.A. His experience in these organizations has contributed to his expertise in pharmaceutical development and innovation.

Collaborations

Spitzley has collaborated with talented individuals in the industry, including Bianca Brögmann and Silke Mühlau. These partnerships have likely enriched his work and led to further advancements in his field.

Conclusion

In summary, Christof Spitzley is a distinguished inventor whose work in pharmaceutical preparations has the potential to significantly impact pain therapy. His innovative approach and collaborations highlight his dedication to improving medical treatments.

Profile summary based on public USPTO records.